Novel Endocrine Therapy Agents in ER-Positive, HER2-Negative Breast Cancer

被引：0
|
作者：
Hamilton, Erika P. [1 ]
Rugo, Hope S. [1 ]
机构：
[1] Sarah Cannon Res Inst, Breast Canc & Gynecol Canc Res, Nashville, TN 37203 USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2023年 / 21卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：125 / 127
页数：3
相关论文
共 50 条
  • [1] Endocrine therapy for ER-positive/HER2-negative metastatic breast cancer
    Reinert, Tomas
    de Paula, Bruno
    Shafaee, Maryam Nemati
    Souza, Pedro Henrique
    Ellis, Matthew J.
    Bines, Jose
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (03)
  • [2] New Approaches to Endocrine Therapy in ER-Positive, HER2-Negative Breast Cancer
    Hamilton, Erika P.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (06) : 356 - 358
  • [3] Biomarkers of neoadjuvant/adjuvant endocrine therapy for ER-positive/HER2-negative breast cancer
    Ueno, Takayuki
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
  • [4] Implementing neoadjuvant endocrine strategies in ER-positive, HER2-negative breast cancer
    Matikas, Alexios
    Foukakis, Theodoros
    Michalakis, Ilias
    Georgoulias, Vassilis
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (04) : 319 - 326
  • [5] Effective sequence of endocrine therapy for ER-positive and HER2-negative metastatic breast cancer.
    Osako, Tomofumi
    Nishimura, Reiki
    Nishiyama, Yasuyuki
    Tashima, Rumiko
    Fujisue, Mamiko
    Nakano, Masahiro
    Toyozumi, Yasuo
    Arima, Nobuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Real-world data on neoadjuvant endocrine therapy in ER-positive/HER2-negative breast cancer
    da Silva, Leonardo Roberto
    de Andrade, Camila Annicchino
    Brenelli, Fabricio
    Ramalho, Susana
    Reinert, Tomas
    de Souza, Alessandra Borba Anton
    da Silva, Ana Elisa Ribeiro
    de Paula Leite Kraft, Maria Beatriz
    de Vasconcelos, Vivian Castro Antunes
    Frasson, Antonio Luiz
    Torresan, Renato Zochio
    Cabello, Cesar
    Ellis, Matthew J.
    Zeferino, Luiz Carlos
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (03) : 753 - 760
  • [7] Real-world data on neoadjuvant endocrine therapy in ER-positive/HER2-negative breast cancer
    Leonardo Roberto da Silva
    Camila Annicchino de Andrade
    Fabrício Brenelli
    Susana Ramalho
    Tomás Reinert
    Alessandra Borba Anton de Souza
    Ana Elisa Ribeiro da Silva
    Maria Beatriz de Paula Leite Kraft
    Vivian Castro Antunes de Vasconcelos
    Antônio Luiz Frasson
    Renato Zochio Torresan
    Cesar Cabello
    Matthew J. Ellis
    Luiz Carlos Zeferino
    Breast Cancer Research and Treatment, 2021, 186 : 753 - 760
  • [8] Elacestrant for ER-Positive HER2-Negative Advanced Breast Cancer
    Hageman, Elizabeth
    Lussier, Mia E.
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (08) : 849 - 856
  • [9] Elacestrant in advanced ER-positive, HER2-negative breast cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (01) : 17 - 17
  • [10] Challenges in the management of advanced, ER-positive, HER2-negative breast cancer
    Christopher D. Hart
    Ilenia Migliaccio
    Luca Malorni
    Cristina Guarducci
    Laura Biganzoli
    Angelo Di Leo
    Nature Reviews Clinical Oncology, 2015, 12 : 541 - 552
12345